Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: Relationship with neurohormonal and inflammatory biomarkers

Metabolism: Clinical and Experimental

Volumn 61, Issue 1, 2012, Pages 37-42

  Tedeschi, Stefano ^a   Pilotti, Elisabetta ^a   Parenti, Elisabetta ^a   Vicini, Vanni ^a   Coghi, Pietro ^a   Montanari, Alberto ^a   Regolisti, Giuseppe ^a   Fiaccadori, Enrico ^a   Cabassi, Aderville ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALBUMIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FATTY ACID; INSULIN; NORADRENALIN; PREALBUMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

AGED; BODY WEIGHT; CACHEXIA; CONFERENCE PAPER; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HEART FAILURE; HUMAN; LIPOLYSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOKINES; AGED; BIOLOGICAL MARKERS; BODY WEIGHT; CACHEXIA; CASE-CONTROL STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; LIPOLYSIS; MALE; NATRIURETIC PEPTIDE, BRAIN; NEUROTRANSMITTER AGENTS; SEMINAL PLASMA PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82955233120     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.011     Document Type: Conference Paper

References (31)

1. S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083 (Pubitemid 36369559)
2. S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053 (Pubitemid 27158249)
3. W.J. Evans, J.E. Morley, and J. Argilés Cachexia: a new definition Clin Nutr 27 2008 793 799
4. S.D. Anker, J.W. Swan, and M. Volterrani The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure Eur Heart J 18 1997 259 269 (Pubitemid 27107588)
5. S.D. Anker, A.L. Clark, and M.M. Teixeira Loss of bone mineral in patients with cachexia due to chronic heart failure Am J Cardiol 83 1999 612 615 (Pubitemid 29100853)
6. C.H. Davos, W. Doehner, and M. Rauchhaus Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity J Card Fail 9 2003 29 35 (Pubitemid 36356699)
7. S.D. Anker, P.P. Ponikowski, and A.L. Clark Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure Eur Heart J 20 1999 683 693 (Pubitemid 29204354)
8. S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534 (Pubitemid 27329429)
9. C. Sengenès, M. Berlan, and I. De Glisezinski Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J 14 2000 1345 1351 (Pubitemid 30439743)
10. P. Bettencourt, A. Azevedo, and J. Pimenta N-terminal-probrain natriuretic peptide predicts outcome after hospital discharge in heart failure patients Circulation 110 2004 2168 2174 (Pubitemid 39372496)
11. A. Vaz Pérez, W. Doehner, and S. von Haehling The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure Int J Cardiol 141 2010 39 43
12. M.J. Tisdale Mechanisms of cancer cachexia Physiol Rev 89 2009 381 410
13. D.M. Selva, A. Lecube, and C. Hernández Lower zinc-alpha2- glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance J Clin Endocrinol Metab 94 2009 4499 4507
14. V. Ceperuelo-Mallafré, S. Näf, and X. Escoté Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat J Clin Endocrinol Metab 94 2009 5062 5069
15. Y. Bao, C. Bing, and L. Hunter Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes FEBS Lett 579 2005 41 47 (Pubitemid 40023371)
16. K. Hirai, H.J. Hussey, and M.D. Barber Biological evaluation of a lipid mobilizing factor isolated from the urine of cancer patients Cancer Res 58 1998 2359 2365 (Pubitemid 28252695)
17. T. Mracek, N.A. Stephens, and D. Gao Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients Br J Cancer 104 2011 441 447
18. L.E. Olofsson, B. Olsson, and T. Lystig Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids Metabolism 59 2010 1316 1318
19. T.D. Smilde, V.J. van Veldhuisen, and G. Navis Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 10 2006 1572 1580 (Pubitemid 44547427)
20. K. Swedberg, J. Cleland, and H. Dargie Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): the Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 26 2005 1115 1140
21. S.A. Hunt, W.T. Abraham, and M.H. Chin Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 90
22. A. Cabassi, S. Vinci, and M. Calzolari Regional sympathetic activity in pre-hypertensive phase of spontaneously hypertensive rats Life Sci 62 1998 1111 1118 (Pubitemid 28085432)
23. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
24. G. Paolisso, S. De Riu, and G. Marrazzo Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure Metabolism 40 1991 972 977
25. J. Lommi, M. Kupari, and H. Yki-Järvinen Free fatty acid kinetics and oxidation in congestive heart failure Am J Cardiol 81 1998 45 50 (Pubitemid 28046841)
26. J.W. Swan, S.D. Anker, and C. Walton Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532 (Pubitemid 27339335)
27. M. Cicoira, A.P. Bolger, and W. Doehner High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients Cytokine 15 2001 80 86 (Pubitemid 34920508)
28. J.A. Engelman, A.H. Berg, and R.Y. Lewis Tumor necrosis factor alpha mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes Mol Endocrinol 14 2000 1557 1569
29. H.H. Zhang, M. Halbleib, and F. Ahmad Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP Diabetes 51 2002 2929 2935
30. A. Philipp, S. Kralisch, and A. Bachmann Serum levels of the adipokine zinc-alpha2-glycoprotein are increased in chronic hemodialysis Metabolism 60 2011 669 672
31. M. Rydén, and P. Arner Fat loss in cachexia-is there a role for adipocyte lipolysis? Clin Nutr 26 2007 1 6 (Pubitemid 46179125)